GCP
BIVI icon

Gill Capital Partners’s BioVie BIVI Stock Holding History

Gill Capital Partners’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3 Buy
+2
New +$3 ﹤0.01% 699

Other funds holding BIVI

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Gill Capital Partners's BIVI Position: Q1 2026 in Review

Gill Capital Partners opened a new position in BioVie (BIVI) in Q1 2026: 2 shares worth $3. The stake represents ﹤0.01% of the portfolio and ranks #699 among its holdings.

33 funds tracked by Wall St. Rank hold BIVI as of Q1 2026.

  • Gill Capital Partners held 2 shares of BioVie worth $3 as of Q1 2026.
  • BioVie was a new Gill Capital Partners position in Q1 2026.
  • BioVie made up ﹤0.01% of Gill Capital Partners's portfolio in Q1 2026, its #699 holding.
  • 33 funds tracked by Wall St. Rank held BioVie as of Q1 2026.

Based on Gill Capital Partners's 13F filing for Q1 2026, filed 13 Apr 2026.